首頁 > 市場調查報告書 > 製藥

酵素

市場調查報告書

商品編碼

1547503

全球醫用酵素技術市場研究報告 - 2024 年至 2032 年產業分析、規模、佔有率、成長、趨勢與預測

Global Medical Enzyme Technology Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2024 to 2032

出版日期: 2024年07月01日 | 出版商:

Value Market Research | 英文 128 Pages | 商品交期: 最快1-2個工作天內

價格

簡介目錄圖表

全球醫用酵素技術市場需求預計將從2023年的60.8億美元達到2032年近109.3億美元的市場規模，2024-2032年研究期間複合年成長率為6.74%。

酵素在動物、植物、人類以及微生物的代謝活動中發揮關鍵作用。因此，它們在微生物生物技術和診斷過程中具有廣泛的用途。酵素透過三種作用機轉發揮作用：打破內部血栓、溶解血管壁硬化、溶解傷口腫脹以促進癒合。因此，酵素可以用作治療一系列疾病的藥物，例如胰蛋白酶用於加速傷口癒合、溶解血栓、去除壞死組織以及抑制污染微生物的增殖。此外，具有抗發炎作用的蛋白酶可用於治療消化不良。此外，脂肪酶、豆粕纖溶酶、超氧化物歧化酶、納豆激酶、凝血酶等可用於治療多種疾病。

市場動態

隨著酵素在疾病預防和治療中的應用不斷增加，對開發先進酵素工程技術的投資不斷增加，以及生物催化劑在醫療領域的廣泛應用帶來的指數級成長，全球醫用酵素技術市場預計將蓬勃發展。透過廣泛的研究，醫用酵素正在探索其在醫療器材清潔、代謝輔助、藥物傳遞、疾病診斷和藥物製造方面的重要性。目前，科學家和研究人員正在集中精力解決傳統醫用酵素技術的缺陷，這將在未來幾年重新定義醫用酵素技術市場。此外，人們正在做出許多努力來增強醫用級酶的熱穩定性和其他性能，這有望改善全球市場的整體前景。

研究報告涵蓋波特五力模型、市場吸引力分析和價值鏈分析。這些工具有助於清晰地了解行業結構並評估全球範圍內的競爭吸引力。此外，這些工具也對全球醫用酵素技術市場的各個細分市場進行了包容性評估。醫用酵素技術產業的成長和趨勢為本研究提供了整體方法。

市場區隔

醫用酶技術市場報告的這一部分提供了國家和區域級別細分市場的詳細資料，從而幫助策略師確定相應產品或服務的目標人群以及即將到來的機會。

依酶類型

消化酵素
水解酶
溶栓酶

按申請

疾病治療
診斷工具
生物醫學研究

區域分析

本節涵蓋區域前景，重點介紹北美、歐洲、亞太地區、拉丁美洲以及中東和非洲醫用酶技術市場當前和未來的需求。此外，該報告重點關注所有主要地區各個應用領域的需求、估計和預測。

該研究報告還涵蓋了市場主要參與者的全面概況以及對全球競爭格局的深入了解。醫用酵素技術市場的主要參與者包括 Thermo Fisher Scientific Inc.、Asahi Kasei Corporation、Merck KgaA、Agilent Technologies Inc.、Novozymes A/S、Promega Corporation、Takeda Pharmaceutical Company Limited、Amano Enzyme Inc.、Sun Pharmaceutical Industries Ltd . ，丹納赫公司。本節包含競爭格局的整體視圖，包括各種策略發展，例如關鍵併購、未來產能、合作夥伴關係、財務概況、合作、新產品開發、新產品發布和其他發展。

如果您有任何客製化要求，請寫信給我們。我們的研究團隊可以根據您的需求提供客製化報告。

區域展望
介紹
北美銷售分析
- 概覽、歷史與預測資料銷售分析
- 北美按細分市場銷售分析
- 北美按國家銷售分析
- 美國銷售分析
- 加拿大銷售分析
- 墨西哥銷售分析
歐洲銷售分析
- 概覽、歷史與預測資料銷售分析
- 歐洲按細分市場銷售分析
- 歐洲按國家銷售分析
- 英國銷售分析
- 法國銷售分析
- 德國銷售分析
- 義大利銷售分析
- 俄羅斯銷售分析
- 歐洲其他地區銷售分析
亞太地區銷售分析
- 概覽、歷史與預測資料銷售分析
- 亞太地區按細分市場銷售分析
- 亞太地區按國家銷售分析
- 中國銷售分析
- 印度銷售分析
- 日本銷售分析
- 韓國銷售分析
- 澳洲銷售分析
- 東南亞銷售分析
- 亞太地區其他地區銷售分析
拉丁美洲銷售分析
- 概覽、歷史與預測資料銷售分析
- 拉丁美洲按細分市場銷售分析
- 拉丁美洲按國家銷售分析
- 巴西銷售分析
- 阿根廷銷售分析
- 秘魯銷售分析
- 智利銷售分析
- 拉丁美洲其他地區銷售分析
中東和非洲銷售分析
- 概覽、歷史與預測資料銷售分析
- 中東和非洲按細分市場銷售分析
- 中東和非洲按國家銷售分析
- 沙烏地阿拉伯銷售分析
- 阿拉伯聯合大公國銷售分析
- 以色列銷售分析
- 南非銷售分析
- 中東其他地區和非洲銷售分析

第8章：醫用酵素技術公司的競爭格局

醫用酵素技術市場競爭
夥伴關係/協作/協議
併購
新產品發布
其他發展

第 9 章：公司簡介

頂級公司市佔率分析
市場集中度
Thermo Fisher Scientific Inc.

公司概況
公司收入
產品
最新動態

Asahi Kasei Corporation

公司概況
公司收入
產品
最新動態

Merck KgaA

公司概況
公司收入
產品
最新動態

Agilent Technologies Inc.

公司概況
公司收入
產品
最新動態

Novozymes A/S

公司概況
公司收入
產品
最新動態

Promega Corporation

公司概況
公司收入
產品
最新動態

Takeda Pharmaceutical Company Limited

公司概況
公司收入
產品
最新動態

Amano Enzyme Inc.

公司概況
公司收入
產品
最新動態

Sun Pharmaceutical Industries Ltd.

公司概況
公司收入
產品
最新動態

Danaher Corporation

公司概況
公司收入
產品
最新動態

註 - 在公司概況中，財務詳細資訊和最新發展視情況而定，或對私人公司而言可能不包括在內

簡介目錄圖表

Product Code: VMR11215141

The global demand for Medical Enzyme Technology Market is presumed to reach the market size of nearly USD 10.93 Billion by 2032 from USD 6.08 Billion in 2023 with a CAGR of 6.74% under the study period 2024-2032.

Enzymes play a critical part in the metabolic activities of animals, plants, humans, as well as microbial. Thus, they have a wide range of uses in microbial biotechnology and diagnosis processes. Enzymes serve to be effective with three action mechanisms: breaking the internal blood clots, dissolving the hardening of walls of blood vessels, and dissolving the wound swelling to promote healing. Thus, enzymes can be used as medicines to treat a range of diseases, such as trypsin used to accelerate wound healing, dissolve blood clots, remove necrotic tissue, and inhibit the proliferation of contaminating microorganisms. In addition, a protease with an anti-inflammatory effect can be used to treat dyspepsia. Moreover, lipase, soybean meal plasmin, superoxide dismutase, nattokinase, and thrombin, among others, can be used to treat various diseases.

MARKET DYNAMICS

The global medical enzyme technology market is anticipated to thrive with escalating adoption of enzymes for disease prevention and treatment, mounting investments toward developing advanced enzyme engineering technologies, and exponential growth due to the broad application of biocatalysts in the medical sector. The medical enzyme is exploring its significance across medical device cleaning, metabolism assistance, drug delivery, disorders diagnosis, and manufacturing of medicines through extensive research. Presently, scientists and researchers are concentrating on addressing the shortcoming of traditional medical enzyme technologies, which is attributed to redefine the medical enzyme technology market in coming years. In addition, many efforts are being made to enhance thermo-stability and other properties of medical-grade enzymes, which are expected to improve the overall prospects of the global market.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of Medical Enzyme Technology. The growth and trends of Medical Enzyme Technology industry provide a holistic approach to this study.

MARKET SEGMENTATION

This section of the Medical Enzyme Technology market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Enzyme Type

Digestive Enzymes
Hydrolases
Thrombolytic Enzymes

By Application

Disease Treatment
Diagnostic Tools
Biomedical Research

REGIONAL ANALYSIS

This section covers the regional outlook, which accentuates current and future demand for the Medical Enzyme Technology market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Medical Enzyme Technology market include Thermo Fisher Scientific Inc., Asahi Kasei Corporation, Merck KgaA, Agilent Technologies Inc., Novozymes A/S, Promega Corporation, Takeda Pharmaceutical Company Limited, Amano Enzyme Inc., Sun Pharmaceutical Industries Ltd., Danaher Corporation. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

1. PREFACE

1.1. Report Description
- 1.1.1 Objective
- 1.1.2 Target Audience
- 1.1.3 Unique Selling Proposition (USP) & offerings
1.2. Research Scope
1.3. Research Methodology
- 1.3.1 Market Research Process
- 1.3.2 Market Research Methodology

2. EXECUTIVE SUMMARY

2.1. Highlights of Market
2.2. Global Market Snapshot

3. MEDICAL ENZYME TECHNOLOGY - INDUSTRY ANALYSIS

3.1. Introduction - Market Dynamics
3.2. Market Drivers
3.3. Market Restraints
3.4. Opportunities
3.5. Industry Trends
3.6. Porter's Five Force Analysis
3.7. Market Attractiveness Analysis
- 3.7.1 Market Attractiveness Analysis By Enzyme Type
- 3.7.2 Market Attractiveness Analysis By Application
- 3.7.3 Market Attractiveness Analysis By Region

4. VALUE CHAIN ANALYSIS

4.1. Value Chain Analysis
4.2. Raw Material Analysis
- 4.2.1 List of Raw Materials
- 4.2.2 Raw Material Manufactures List
- 4.2.3 Price Trend of Key Raw Materials
4.3. List of Potential Buyers
4.4. Marketing Channel
- 4.4.1 Direct Marketing
- 4.4.2 Indirect Marketing
- 4.4.3 Marketing Channel Development Trend

5. GLOBAL MEDICAL ENZYME TECHNOLOGY MARKET ANALYSIS BY ENZYME TYPE

5.1. Overview By Enzyme Type
5.2. Historical and Forecast Data Analysis By Enzyme Type
5.3. Digestive Enzymes Historic and Forecast Sales By Regions
5.4. Hydrolases Historic and Forecast Sales By Regions
5.5. Thrombolytic Enzymes Historic and Forecast Sales By Regions

6. GLOBAL MEDICAL ENZYME TECHNOLOGY MARKET ANALYSIS BY APPLICATION

6.1. Overview By Application
6.2. Historical and Forecast Data Analysis By Application
6.3. Disease Treatment Historic and Forecast Sales By Regions
6.4. Diagnostic Tools Historic and Forecast Sales By Regions
6.5. Biomedical Research Historic and Forecast Sales By Regions

7. GLOBAL MEDICAL ENZYME TECHNOLOGY MARKET ANALYSIS BY GEOGRAPHY

7.1. Regional Outlook
7.2. Introduction
7.3. North America Sales Analysis
- 7.3.1 Overview, Historic and Forecast Data Sales Analysis
- 7.3.2 North America By Segment Sales Analysis
- 7.3.3 North America By Country Sales Analysis
- 7.3.4 United States Sales Analysis
- 7.3.5 Canada Sales Analysis
- 7.3.6 Mexico Sales Analysis
7.4. Europe Sales Analysis
- 7.4.1 Overview, Historic and Forecast Data Sales Analysis
- 7.4.2 Europe By Segment Sales Analysis
- 7.4.3 Europe By Country Sales Analysis
- 7.4.4 United Kingdom Sales Analysis
- 7.4.5 France Sales Analysis
- 7.4.6 Germany Sales Analysis
- 7.4.7 Italy Sales Analysis
- 7.4.8 Russia Sales Analysis
- 7.4.9 Rest Of Europe Sales Analysis
7.5. Asia Pacific Sales Analysis
- 7.5.1 Overview, Historic and Forecast Data Sales Analysis
- 7.5.2 Asia Pacific By Segment Sales Analysis
- 7.5.3 Asia Pacific By Country Sales Analysis
- 7.5.4 China Sales Analysis
- 7.5.5 India Sales Analysis
- 7.5.6 Japan Sales Analysis
- 7.5.7 South Korea Sales Analysis
- 7.5.8 Australia Sales Analysis
- 7.5.9 South East Asia Sales Analysis
- 7.5.10 Rest Of Asia Pacific Sales Analysis
7.6. Latin America Sales Analysis
- 7.6.1 Overview, Historic and Forecast Data Sales Analysis
- 7.6.2 Latin America By Segment Sales Analysis
- 7.6.3 Latin America By Country Sales Analysis
- 7.6.4 Brazil Sales Analysis
- 7.6.5 Argentina Sales Analysis
- 7.6.6 Peru Sales Analysis
- 7.6.7 Chile Sales Analysis
- 7.6.8 Rest of Latin America Sales Analysis
7.7. Middle East & Africa Sales Analysis
- 7.7.1 Overview, Historic and Forecast Data Sales Analysis
- 7.7.2 Middle East & Africa By Segment Sales Analysis
- 7.7.3 Middle East & Africa By Country Sales Analysis
- 7.7.4 Saudi Arabia Sales Analysis
- 7.7.5 UAE Sales Analysis
- 7.7.6 Israel Sales Analysis
- 7.7.7 South Africa Sales Analysis
- 7.7.8 Rest Of Middle East And Africa Sales Analysis

8. COMPETITIVE LANDSCAPE OF THE MEDICAL ENZYME TECHNOLOGY COMPANIES

8.1. Medical Enzyme Technology Market Competition
8.2. Partnership/Collaboration/Agreement
8.3. Merger And Acquisitions
8.4. New Product Launch
8.5. Other Developments

9. COMPANY PROFILES OF MEDICAL ENZYME TECHNOLOGY INDUSTRY

9.1. Top Companies Market Share Analysis
9.2. Market Concentration Rate
9.3. Thermo Fisher Scientific Inc.
- 9.3.1 Company Overview
- 9.3.2 Company Revenue
- 9.3.3 Products
- 9.3.4 Recent Developments
9.4. Asahi Kasei Corporation
- 9.4.1 Company Overview
- 9.4.2 Company Revenue
- 9.4.3 Products
- 9.4.4 Recent Developments
9.5. Merck KgaA
- 9.5.1 Company Overview
- 9.5.2 Company Revenue
- 9.5.3 Products
- 9.5.4 Recent Developments
9.6. Agilent Technologies Inc.
- 9.6.1 Company Overview
- 9.6.2 Company Revenue
- 9.6.3 Products
- 9.6.4 Recent Developments
9.7. Novozymes A/S
- 9.7.1 Company Overview
- 9.7.2 Company Revenue
- 9.7.3 Products
- 9.7.4 Recent Developments
9.8. Promega Corporation
- 9.8.1 Company Overview
- 9.8.2 Company Revenue
- 9.8.3 Products
- 9.8.4 Recent Developments
9.9. Takeda Pharmaceutical Company Limited
- 9.9.1 Company Overview
- 9.9.2 Company Revenue
- 9.9.3 Products
- 9.9.4 Recent Developments
9.10. Amano Enzyme Inc.
- 9.10.1 Company Overview
- 9.10.2 Company Revenue
- 9.10.3 Products
- 9.10.4 Recent Developments
9.11. Sun Pharmaceutical Industries Ltd.
- 9.11.1 Company Overview
- 9.11.2 Company Revenue
- 9.11.3 Products
- 9.11.4 Recent Developments
9.12. Danaher Corporation
- 9.12.1 Company Overview
- 9.12.2 Company Revenue
- 9.12.3 Products
- 9.12.4 Recent Developments